Spots Global Cancer Trial Database for ototoxicity
Every month we try and update this database with for ototoxicity cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Cancer and Hearing Loss Related in Children | NCT02425397 | Cancer in Child... Hearing Loss | Genetic study Genetic study M... | 4 Years - | Assistance Publique - Hôpitaux de Paris | |
| Association Between Tinnitus and Hearing Loss in Locally Advanced Head and Neck Cancer Treated by Radiotherapy Alone or With Chemotherapy: a Prospective and Multicenter Study | NCT05946577 | Head Cancer Neck Cancer | 18 Years - | Assistance Publique - Hôpitaux de Paris | ||
| Treatment of Radiation and Cisplatin Induced Toxicities With Tempol | NCT03480971 | Mucositis Nephrotoxicity Ototoxicity | Tempol Placebo Solutio... | 18 Years - | Matrix Biomed, Inc. | |
| Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma | NCT05641441 | Vestibular Schw... Ototoxicity | Stereotactic ra... | 18 Years - | University Hospital, Geneva | |
| Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy | NCT01848457 | Osteosarcoma Nephrotoxicity Ototoxicity | Pantoprazole High-dose metho... | - 30 Years | Children's Hospital of Philadelphia | |
| Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment | NCT04262336 | Ototoxicity | DB-020 Placebo | 18 Years - | Decibel Therapeutics | |
| Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin | NCT00477607 | Ototoxicity Unspecified Adu... | alpha-lipoic ac... Audiology laboratory biom... Placebo | 18 Years - | VA Office of Research and Development | |
| Screening for Hearing Loss After Childhood Cancer | NCT06036407 | Childhood Cance... Hearing Loss | Hearing test | 18 Years - | University of Bern | |
| Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors | NCT01216800 | Head and Neck C... Ototoxicity Radiation Toxic... | adjuvant therap... assessment of t... quality-of-life... 3-dimensional c... intensity-modul... | 18 Years - | National Cancer Institute (NCI) | |
| SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss | NCT01451853 | Lung Cancer Head and Neck C... Hearing Loss Ototoxicity Tinnitus Neuropathy | SPI-1005 Low Do... SPI-1005 Middle... SPI-1005 High D... Placebo | 19 Years - 80 Years | Sound Pharmaceuticals, Incorporated | |
| Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy | NCT01848457 | Osteosarcoma Nephrotoxicity Ototoxicity | Pantoprazole High-dose metho... | - 30 Years | Children's Hospital of Philadelphia | |
| Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment | NCT04262336 | Ototoxicity | DB-020 Placebo | 18 Years - | Decibel Therapeutics | |
| Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer | NCT03400709 | Cisplatin Adver... Hearing Loss Ot... | N Acetylcystein... Placebo Oral Ta... | 18 Years - | Hospital San Juan de Dios, Santiago | |
| The Platinum Study Comparison Group | NCT02890030 | Testicular Neop... | Questionnaire | 18 Years - 55 Years | Indiana University | |
| Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin | NCT00458887 | Ototoxicity Unspecified Chi... | management of t... | 1 Year - 18 Years | Children's Oncology Group | |
| Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy | NCT00716976 | Brain Tumor Central Nervous... Childhood Germ ... Extragonadal Ge... Liver Cancer Neuroblastoma Ototoxicity Ovarian Cancer Sarcoma | sodium thiosulf... examination | 1 Year - 18 Years | Children's Oncology Group | |
| Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin | NCT00458887 | Ototoxicity Unspecified Chi... | management of t... | 1 Year - 18 Years | Children's Oncology Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
